2m 2m 2m 2m 2m 2m 2m
Haemonetics (HAE)
NYSE
$76.90+$0.01 (+0.01%)
Price as of Jul 13, 2026 6:18 PM EDT- $3.5BMarket Cap
- 0.30%1-Year Change
- Medical DevicesIndustry
Haemonetics (HAE)
$76.90+$0.01 (+0.01%)
HAE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $76.89 | ||
Change | +$0.70 (+0.92%) | ||
Open | $75.65 | ||
High | $77.75 | ||
Low | $75.65 | ||
Previous Close | $76.19 | ||
Volume | 691,162 | ||
30-Day Average Volume | 811,687 | ||
1-Week Change | 2.49% | ||
1-Month Change | -1.68% | ||
1-Year Change | 0.30% | ||
3-Year Change | -10.27% | ||
5-Year Change | 24.26% | ||
Fundamentals | |||
Shares Outstanding | 45.4M | ||
Total Assets | $2.4B | ||
Market Cap | $3.5B | ||
Enterprise Value | $4.4B | ||
Period: QTR TTM FY | |||
Revenue | $346.4M | ||
Net Income | -$20.1M | ||
Free Cash Flow | $53.3M | ||
EBIT | -$28.1M | ||
EBITDA | -$780,000.00 | ||
Net Working Capital | $552.3M | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | -5,694 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 4 | ||
P/E | -175 | ||
PEG | 1 | ||
Price/Free Cash Flow | 65 | ||
Price/Operating Cash Flow | 49 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 12/03/2012 | ||
Earnings & Revenue